OraSure partners with Walgreens to promote HIV testing
Initially, Walgreens and OraSure will provide the OraQuick In-Home HIV Test Retail Access Cards to Housing Works, a New-York City-based public health organization.
Trend toward self-management fuels growth of diabetes device sales
CVS Health to mark National Influenza Vaccination Week
Kroger, APhA Foundation to help CDC scale National Diabetes Prevention Program
Semma Therapeutics developing stem cell therapy for Type 1 diabetes
The company is working on developing transformative stem cell-driven therapy focusing on a new treatment for Type 1 Diabetes Mellitus.
CVS Health offers pharmacists, prescribers real-time benefit info for Caremark members
CVS Caremark will offer visibility of costs and lower-cost alternatives at point of prescribing and at the pharmacy in an effort to cut down on dispensing delays and improve patient outcomes, the Woonsocket, R.I.-based company said.
Takeda kicks off trial for Zika vaccine
Takeda said that in addition to its work on the Zika vaccine, it is undertaking vaccine programs to address such illnesses as dengue, norovirus and polio.
Teva restructures, shuffles executive team
Under the new structure, the global generics and specialty medicines groups will be integrated into a single commercial organization covering North America, Europe and growth markets. Each region will manage the entire portfolio from OTC to specialty and generic pharmaceuticals.
Upsher-Smith relaunches Klor-Con powder
The company noted that the relaunched generic potassium chloride powder would be available with a new NDC number.
NACDS evaluates CMS’ proposed rule for pharmacy progress
Walgreens study finds results from pharmacy, specialty clinic collaboration
Hepatitis C patients managed jointly by this clinic-pharmacy collaboration had a shorter average prescribed time-to-therapy and lower copays.
Perrigo launches 2 generics
Perrigo has introduced its generics of Mycolog II Cream (nystatin and triamcinolone acetonide cream, 1 mg/gram) and the Exalgo (hydromorphone HCl) extended-release tablets in 32-mg dosage strength.
Cowen assesses Amazon’s Rx potential, marks RAD as prime acquisition target
New York-based equity research firm Cowen has sized up the threat Amazon poses to the industry, and while its entry would not be as disruptive as some might think, there are still opportunities for Amazon in the pharmacy business.